TSLNC8 has been shown to modulate STAT3 phosphorylation levels (Tyr705 and Ser727) and transcriptional activity through competitive interactions with transketolase and STAT3, resulting in inactivation of the IL-6/STAT3 signaling pathway in HCC cells. This evidence concerns the gene STAT3 and hepatocellular carcinoma.